|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Aspergillosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 ... newer antifungal agents such as rezafungin and isavuconazole against ... experiencing serious infections. Consequently, rezafungin, a next-generation echinocandin, could ... making it a valuable alternative to voriconazole. Rezafungin is a novel echinocandin with ... Candidemia - Pipeline Insight - 2020 ... Candidemia Emerging Drugs Rezafungin acetate: Cidara Therapeutics Rezafungin acetate is a drug that ... was owned by Seachaid Pharmaceuticals. Rezafungin acetate is now licensed by Mundipharma ... Pharmaceuticals Key Products Rezafungin acetate Fosmanogepix Candidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 ... United Kingdom (U.K.) approved REZZAYO (rezafungin acetate) for the management of invasive ... ' and Cidara Therapeutics' Rezzayo (rezafungin acetate) for the treatment of ... ranging from 5% to 71%. Drugs: REZZAYO (rezafungin for injection) is a new once-weekly ... Candidemia – Market Insights, Epidemiology, and Market Forecast—2030 ... , molds, and endemic mycoses. Rezafungin: Cidara Therapeutics Rezafungin, also known as CD101 is a novel ... and prevention of serious fungal infections. Rezafungin is a member of the echinocandin class of drugs ... Global Caspofungin Market Size study & Forecast, by Indication (Candidiasis, Thrush, Other Indications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2023-2030 ... FDA) for Rezayyo, an injectable form of rezafungin. This approval signifies its effectiveness ... Phase 3 ReSTORE clinical trial evaluating rezafungin for the treatment of candidemia ... efficacy and safety profile for rezafungin. Global Caspofungin Market Report ... Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Drugs In Development, 2022, provides an ... Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis Candidiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Candidiasis Infection pipeline products. DISEASE OVERVIEW Candidiasis infection is spread through Clostridium ... Coccidioidomycosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Coccidioidomycosis Coccidioidomycosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Coccidioidomycosis Infection pipeline products. DISEASE OVERVIEW Coccidioidomycosis infection is spread ... Sepsis - Pipeline Insight, 2021 ... Thymosin alpha 1 VBI-S Vilobelimab Albutein Rezafungin Recombinant human alkaline phosphatase ART ... Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In Development, 2022, provides an ... Global Invasive Fungal Infection Market Size Study & Forecast, by Disease Type (Candidaemi Caa and Invasive Candiasis, Intra-abdominal Candiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Others), By Drug Type (Polyenes, Amphotericin B Deoxycholate, Lipid Formulation Amphotericin B, Others), and Regional Analysis, 2023-2030 ... (FDA) has granted approval for rezafungin for injection, (REZZAYOTM), as a treatment for ... Global ?-1,3 Glucan Market Growth 2025-2031 ... . The new drugs ibrexafungerp and rezafungin United States market for ?-1,3 Glucan ... Fungal Lung Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major fungal lung diseases markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The fungal lung diseases market has been comprehensively analyzed in IMARC's new report titled "Fungal Lung Diseases Market: Epidemiology, Industry Trends, ... Invasive Candidiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major invasive candidiasis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.12% during 2024-2034. The invasive candidiasis market ... Antibiotics and Antimycotics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Penicillins, Cephalosporins, Carbapenems, Macrolides, Aminoglycosides, Quinolones, Sulfonamides, Tetracyclines, Azoles, and Others), Indication (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, and Others), Route of Administration (Oral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) ... 2023, The US FDA approved REZZAYO (rezafungin for injection) for the treatment ... Global Fungal ?-glucan Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... . The new drugs ibrexafungerp and rezafungin This report is a detailed and comprehensive ... Global ?-1,3 Glucan Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... . The new drugs ibrexafungerp and rezafungin This report is a detailed and comprehensive ... Global Fungal ?-glucan Market Growth 2025-2031 ... . The new drugs ibrexafungerp and rezafungin United States market for Fungal ... Mundipharma International Ltd - Strategic SWOT Analysis Review ... 04,2019: Cidara and Mundipharma sign rezafungin drug development deal Jun 14,2019 ... |